EML4-ALK V3, treatment resistance, and survival: refining the diagnosis of ALK⁺ NSCLC

J Thorac Dis. 2018 Jun;10(Suppl 17):S1989-S1991. doi: 10.21037/jtd.2018.05.61.

Authors

Petros Christopoulos^{1

2}, Martina Kirchner^{2

3}, Volker Endris^{2

3}, Albrecht Stenzinger^{2

3}, Michael Thomas^{1

2}

Affiliations

¹ Department of Thoracic Oncology, Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany.
² Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany.
³ Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.

No abstract available

Publication types

Editorial